Meeting Coverage:

American Academy of Ophthalmology

AAO: 2023

A New Approach to Combatting Blindness in RP

Show Description +

Russell N. Van Gelder, MD, PhD, discusses Kiora Pharmaceutical’s novel molecular photoswitch, KIO-301; in the phase 1b trial, treatment provided some visual benefit to patients with extensive vision loss due to retinitis pigmentosa.

Posted: 11/29/2023

Up Next


Diversity in Ocular Oncology

Basil K. Williams Jr, MD

Update on Glaucoma Lasers

Aaki Shukla, MD, and Mary Qiu, MD

Genetics: Now or Later

Inas Aboobakar, MD

Drug-Eluting IOLs

Kenneth Mandell, MD, PhD

Pearls for Subretinal Gene Therapy

Christina Y. Weng, MD, MBA

A CRISPR Gene Editing Update

Glenn Yiu, MD, PhD

A New Approach to Combatting Blindness in RP

Russell N. Van Gelder, MD, PhD, discusses Kiora Pharmaceutical’s novel molecular photoswitch, KIO-301; in the phase 1b trial, treatment provided some visual benefit to patients with extensive vision loss due to retinitis pigmentosa.

Posted: 11/29/2023


Please log in to leave a comment.

More From AAO: 2023 Coverage